231 related articles for article (PubMed ID: 12207741)
1. Aberrant expression of p16 and RB protein in eccrine porocarcinoma.
Gu LH; Ichiki Y; Kitajima Y
J Cutan Pathol; 2002 Sep; 29(8):473-9. PubMed ID: 12207741
[TBL] [Abstract][Full Text] [Related]
2. Altered Rb, p16, and p53 expression is specific for porocarcinoma relative to poroma.
Zahn J; Chan MP; Wang G; Patel RM; Andea AA; Bresler SC; Harms PW
J Cutan Pathol; 2019 Sep; 46(9):659-664. PubMed ID: 31012122
[TBL] [Abstract][Full Text] [Related]
3. p53 protein and proliferating cell nuclear antigen in eccrine poroma and porocarcinoma. an immunohistochemical study.
Tateyama H; Eimoto T; Tada T; Inagaki H; Nakamura T; Yamauchi R
Am J Dermatopathol; 1995 Oct; 17(5):457-64. PubMed ID: 8599450
[TBL] [Abstract][Full Text] [Related]
4. P53 protein expression in eccrine poroma and porocarcinoma.
Akalin T; Sen S; Yücetürk A; Kandiloğlu G
Am J Dermatopathol; 2001 Oct; 23(5):402-6. PubMed ID: 11801771
[TBL] [Abstract][Full Text] [Related]
5. Intracranial extension of an eccrine porocarcinoma. Case report and review of the literature.
Ritter AM; Graham RS; Amaker B; Broaddus WC; Young HF
J Neurosurg; 1999 Jan; 90(1):138-40. PubMed ID: 10413167
[TBL] [Abstract][Full Text] [Related]
6. Eccrine porocarcinoma treated with Mohs micrographic surgery: A report of five cases.
Wittenberg GP; Robertson DB; Solomon AR; Washington CV
Dermatol Surg; 1999 Nov; 25(11):911-3. PubMed ID: 10594609
[TBL] [Abstract][Full Text] [Related]
7. Eccrine porocarcinoma with Bowenoid changes: epithelial membrane antigen is not a useful marker for malignant tumours arising from eccrine gland structures.
Mariko O; Sotoh T; Yokozeki H; Nishioka K
Acta Derm Venereol; 2004; 84(2):142-4. PubMed ID: 15206695
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry of eccrine poroma and porocarcinoma--more than acrosyringeal tumors?
Wollina U; Castelli E; Rülke D
Recent Results Cancer Res; 1995; 139():303-16. PubMed ID: 7541147
[TBL] [Abstract][Full Text] [Related]
9. Eccrine porocarcinoma: a case report.
Vandeweyer E; Renorte C; Musette S; Gilles A
Acta Chir Belg; 2006; 106(1):121-3. PubMed ID: 16612934
[TBL] [Abstract][Full Text] [Related]
10. Eccrine porocarcinoma of the upper eyelid.
Jain R; Prabhakaran VC; Huilgol SC; Gehling N; James CL; Selva D
Ophthalmic Plast Reconstr Surg; 2008; 24(3):221-3. PubMed ID: 18520840
[TBL] [Abstract][Full Text] [Related]
11. Clear-cell porocarcinoma in situ: a cytologic variant of porocarcinoma in situ.
Rutten A; Requena L; Requena C
Am J Dermatopathol; 2002 Feb; 24(1):67-71. PubMed ID: 11803286
[TBL] [Abstract][Full Text] [Related]
12. Eccrine porocarcinoma (malignant eccrine poroma).
Perna C; Cuevas J; Jiménez-Heffernan JA; Hardisson D; Contreras F
Am J Surg Pathol; 2002 Feb; 26(2):272-4. PubMed ID: 11812953
[No Abstract] [Full Text] [Related]
13. Porocarcinoma of the heel. A case report with unusual histologic features.
D'Amato MS; Patterson RH; Guccion JG; White JC; Krasnow SH
Cancer; 1996 Aug; 78(4):751-7. PubMed ID: 8756368
[TBL] [Abstract][Full Text] [Related]
14. Poroma: a review of eccrine, apocrine, and malignant forms.
Sawaya JL; Khachemoune A
Int J Dermatol; 2014 Sep; 53(9):1053-61. PubMed ID: 24697501
[TBL] [Abstract][Full Text] [Related]
15. Eccrine carcinoma (nodular porocarcinoma) of the vulva.
Liegl B; Regauer S
Histopathology; 2005 Sep; 47(3):324-6. PubMed ID: 16115237
[No Abstract] [Full Text] [Related]
16. Eccrine porocarcinoma.
Affleck AG; Bong JL; Ostroumova MA; Leach IH; Perks AG; Varma S
Dermatol Online J; 2006 Jan; 12(1):17. PubMed ID: 16638385
[TBL] [Abstract][Full Text] [Related]
17. [Eccrine porocarcinoma of the head. Report 3 cases].
Gerber PA; Bruch-Gerharz D; Schulte KW; Ruzicka T; Megahed M
Hautarzt; 2005 Apr; 56(4):366-8. PubMed ID: 15750674
[No Abstract] [Full Text] [Related]
18. A case of multiple eccrine porocarcinoma with stepping-stone distribution on the foot.
Ujihara M; Hamanaka S; Hamanaka Y; Kamei T
J Dermatol; 1995 Jun; 22(6):450-7. PubMed ID: 7650246
[TBL] [Abstract][Full Text] [Related]
19. Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomas.
Bosic M; Kirchner M; Brasanac D; Leichsenring J; Lier A; Volckmar AL; Oliveira C; Buchhalter I; Stögbauer F; Zivkovic-Perisic S; Goeppert B; Schirmacher P; Penzel R; Endris V; Stenzinger A
Pathology; 2018 Apr; 50(3):327-332. PubMed ID: 29269125
[TBL] [Abstract][Full Text] [Related]
20. CD117 (KIT) is a useful immunohistochemical marker for differentiating porocarcinoma from squamous cell carcinoma.
Goto K; Takai T; Fukumoto T; Anan T; Kimura T; Ansai S; Oshitani Y; Murata Y; Sakuma T; Hirose T
J Cutan Pathol; 2016 Mar; 43(3):219-26. PubMed ID: 26449497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
